Written Question · S5W-18970 · Session 5
Whether it will provide an update on progress being made to deliver the recommendations of the Montgomery Review of Access to New Medicines.
The question
To ask the Scottish Government whether it will provide an update on progress being made to deliver the recommendations of the Montgomery Review of Access to New Medicines.
The answer
We are continuing to work towards the implementation of the recommendations from the Review of Access to New Medicines.
Recent developments include the publication of the Access to Medicines Data Scoping Taskforce Report “Building Capability to Assess Real-World Benefits, Risk and Value of Medicines: Towards a Scottish Medicines Intelligence Unit”. The new “Ultra-Orphan” decision pathway will also begin to come into place from October 2018. And the Scottish Medicines Consortium (SMC) continues to enhance its effectiveness and accessibility to the public, and has now begun to publish new explanatory leaflets about individual decisions.
From August 2018, the SMC also introduced interim accepted advice for medicines with a conditional marketing authorisation from the European Medicines Agency.
Recent developments include the publication of the Access to Medicines Data Scoping Taskforce Report “Building Capability to Assess Real-World Benefits, Risk and Value of Medicines: Towards a Scottish Medicines Intelligence Unit”. The new “Ultra-Orphan” decision pathway will also begin to come into place from October 2018. And the Scottish Medicines Consortium (SMC) continues to enhance its effectiveness and accessibility to the public, and has now begun to publish new explanatory leaflets about individual decisions.
From August 2018, the SMC also introduced interim accepted advice for medicines with a conditional marketing authorisation from the European Medicines Agency.
In the Official Report
No contribution in the Official Report cites S5W-18970 by reference.